Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.60 Analyst target: $2.54 Upside: -2.38%
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.
See the full interactive analysis & chart →Informational only — not investment advice.